Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Versant Ventures
About
Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
- Menlo Park,California,United States
Details
- Industries
- Financial Services,Health Care,Venture Capital
- Founded date
- Jan 1, 1999
- Operating Status
- Active
- Legal Name
- Versant Ventures
- Investor Type
- Venture Capital
Versant Ventures is a healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in Canada, the U.S., and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 65 Versant companies have achieved successful acquisitions or IPOs.
Funds Raised
| Announced Date | Fund Name | Money Raised | |
|---|---|---|---|
| Apr 21, 2021 | Versant Venture Capital VIII | $560M | |
| Apr 21, 2021 | Versant Voyageurs II | $140M | |
| Apr 16, 2021 | Versant Vantage II | $250M | |
| Dec 17, 2018 | Versant Voyageurs I | $102.24M | |
| Dec 14, 2018 | Versant Venture Capital VII | $600M |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Apr 20, 2023
Abdera Therapeutics
|
Series A | — | Biotechnology | Yes |
|
Jan 4, 2023
Belharra Therapeutics
|
Series A | $50M | Biotechnology | Yes |
|
Dec 12, 2022
Launchpad Therapeutics
|
Series A | $30M | Life Science | Yes |
|
Nov 30, 2022
iECURE
|
Series A | $65M | Biotechnology | — |
|
Nov 15, 2022
Jnana Therapeutics
|
Series C | $107M | Biotechnology | — |
Employee Profiles
Exits
Versant Ventures has had 100 exits. Versant Ventures most notable exits include AcuFocus , Ivantis
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 17, 2023 | AcuFocus | M&A | Health Care | Detail |
| Nov 8, 2021 | Ivantis | M&A | Health Care | Detail |
| Oct 21, 2021 | Minerva Surgical | IPO | Health Care | Detail |
| Sep 21, 2021 | Gotham Therapeutics | M&A | Biotechnology | Detail |
| Aug 5, 2021 | Vividion Therapeutics | M&A | Biotechnology | Detail |
